About Imeka
Imeka is a company based in Sherbrooke (Canada) founded in 2011. Imeka has raised $850 thousand across 3 funding rounds from investors including Alzheimer's Drug Discovery, Sherbrooke Innopole and Hacking Health Accelerator. Imeka offers products and services including ANDI. Imeka operates in a competitive market with competitors including Siemens Healthineers, Qure.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
- Headquarter Sherbrooke, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imeka Solutions Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$850 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Alzheimer's Drug Discovery
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imeka
Imeka offers a comprehensive portfolio of products and services, including ANDI.
AI software for detailed analysis of brain white matter in diagnostics.
People of Imeka
Unlock access to complete
Unlock access to complete
Funding Insights of Imeka
Imeka has successfully raised a total of $850K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Imeka
Imeka has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Alzheimer's Drug Discovery, Sherbrooke Innopole and Hacking Health Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Imeka
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imeka
Investment portfolio details for Imeka
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imeka
Detailed financials for Imeka
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imeka Comparisons
Peer comparison for Imeka
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imeka
Imeka operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siemens Healthineers, Qure.ai, Subtle Medical, Perspectum and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
Provide contract research imaging services and software
|
Detailed competitors of Imeka
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imeka
Complete news archive for Imeka
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imeka
Imeka was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Imeka is headquartered in Sherbrooke, Canada. It is registered at Sherbrooke, Quebec, Canada.
Imeka is a funded company, having raised a total of $850K across 3 funding rounds to date.
Imeka was founded in 2011 in Sherbrooke, Canada, within the medical imaging sector. Software is provided that integrates diffusion imaging and AI to assess white matter integrity. Features such as DTI to HARDI transitions, free-water imaging, tractography, and fiber bundling are included, supported by AI. The platform is applied in clinical trials for site management and subject recruitment, yielding insights into neuroinflammation, demyelination, and axonal loss.
Imeka's top competitors include Perspectum, Qure.ai and Subtle Medical.
Imeka offers ANDI.
Imeka has 6 investors. Key investors include Alzheimer's Drug Discovery, Sherbrooke Innopole, Hacking Health Accelerator, Fonds Innovexport, and Desjardins-Innovatech.